Lenvatinib-d4 is a deuterium-labeled derivative of Lenvatinib, a multi-targeted tyrosine kinase inhibitor. It primarily targets vascular endothelial growth factor receptors (VEGFR1-3), fibroblast growth factor receptors (FGFR1-4), platelet-derived growth factor receptor (PDGFR), KIT, and RET, exhibiting strong antitumor activity. This stable isotope is valuable for metabolic studies, pharmacokinetic profiling, and mechanism of action investigations in cancer research.
Lenvatinib-d4 is a deuterium-labeled derivative of Lenvatinib, a multi-targeted tyrosine kinase inhibitor. It primarily targets vascular endothelial growth factor receptors (VEGFR1-3), fibroblast growth factor receptors (FGFR1-4), platelet-derived growth factor receptor (PDGFR), KIT, and RET, exhibiting strong antitumor activity. This stable isotope is valuable for metabolic studies, pharmacokinetic profiling, and mechanism of action investigations in cancer research.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
